The arisal of data spaces: why I am excited and worried

Front Immunol. 2024 Oct 22:15:1461361. doi: 10.3389/fimmu.2024.1461361. eCollection 2024.

Abstract

This paper explores the significant role of real-world data (RWD) in advancing our understanding and management of Multiple Sclerosis (MS). RWD has proven invaluable in MS research and care, offering insights from larger and diverse patient populations. A key focus of the paper is the European Health Data Space (EHDS), a significant development that promises to change how healthcare data is managed across Europe. This initiative is particularly relevant to the MS community. The paper highlights various data initiatives, discussing their importance for those affected by MS. Despite the potential benefits, there are challenges and concerns, especially about ensuring that the growth of various data platforms remains beneficial for MS patients. The paper suggests practical actions for the global MS community to consider, aimed at optimizing the use of RWD. The emphasis of this discussion is on the secondary use of health data, particularly in the European context. The content is based on the author's own experiences and interpretations, offering a personal yet informed view on using RWD to improve MS research and patient care.

Keywords: European Health Data Space; collaborative research; data interoperability; real-world data; secondary use of health data.

MeSH terms

  • Europe
  • Humans
  • Multiple Sclerosis* / diagnosis
  • Multiple Sclerosis* / therapy

Grants and funding

The author(s) declare that no financial support was received for the research, authorship, and/or publication of this article.